{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-066162","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.377667+00:00","generated_at":"2026-06-01T07:39:00.212498+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Fortress Biotech shareholders approve director slate, KPMG ratification, and equity plan share increases","bullets":["Elected all 8 directors; Rosenwald received 7.88M for, 279K against; broker non-votes 6.1M.","Ratified KPMG as auditor for FY2024 with 13.93M for, 325K against.","Approved Incentive Plan amendment adding 10M shares and raising annual option/SAR limit to 1M shares.","Approved ESPP amendment adding 1M shares and raising Offering limit to 5,000 shares.","Approved LTIP amendment extending term to July 15, 2035 with related changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-066162","json":"https://secwatch.observer/filing/0001104659-24-066162.json","markdown":"https://secwatch.observer/filing/0001104659-24-066162.md","text":"https://secwatch.observer/filing/0001104659-24-066162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924066162/0001104659-24-066162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924066162/tm2415823d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:39:00.212498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}